These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23217603

  • 1. Levamisole is an effective immunomodulator for patients with oral lichen planus.
    Chiang CP.
    J Formos Med Assoc; 2012 Nov; 111(11):661. PubMed ID: 23217603
    [No Abstract] [Full Text] [Related]

  • 2. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
    Sun A, Chia JS, Wang JT, Chiang CP.
    Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
    [Abstract] [Full Text] [Related]

  • 3. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
    Lin HP, Wang YP, Chia JS, Sun A.
    J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152
    [Abstract] [Full Text] [Related]

  • 4. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
    Wu KM, Wang YP, Lin HP, Chen HM, Chia JS, Sun A.
    J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020
    [Abstract] [Full Text] [Related]

  • 5. Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
    Lu SY, Chang TF, Lin CJ.
    J Formos Med Assoc; 2019 Aug; 118(8):1193-1201. PubMed ID: 30922614
    [Abstract] [Full Text] [Related]

  • 6. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.
    Lu SY, Chen WJ, Eng HL.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Oct; 86(4):438-45. PubMed ID: 9798228
    [Abstract] [Full Text] [Related]

  • 7. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
    Lin HP, Wang YP, Chia JS, Sun A.
    J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
    [Abstract] [Full Text] [Related]

  • 8. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
    Sun A, Chiang CP.
    J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157
    [Abstract] [Full Text] [Related]

  • 9. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
    Sun A, Chia JS, Chang YF, Chiang CP.
    J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
    [Abstract] [Full Text] [Related]

  • 10. Sublingual surprise: a new variant of oral lichen planus.
    Jin X, Hu T, Zhao X, Chen Q, Zeng X.
    Am J Med; 2014 Jan; 127(1):28-30. PubMed ID: 24384098
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.
    Lin HP, Wang YP, Chia JS, Chiang CP, Sun A.
    Oral Dis; 2011 Jan; 17(1):95-101. PubMed ID: 20659263
    [Abstract] [Full Text] [Related]

  • 12. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
    Sun A, Chiang CP, Chiou PS, Wang JT, Liu BY, Wu YC.
    J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
    [Abstract] [Full Text] [Related]

  • 13. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study.
    Lu SY, Chen WJ, Eng HL.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):705-9. PubMed ID: 8680979
    [Abstract] [Full Text] [Related]

  • 14. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
    Sun A, Wang JT, Chia JS, Chiang CP.
    Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of clinical data and immuno-modulating treatment of patients with oral lichen planus].
    Kövesi G.
    Fogorv Sz; 2001 Feb; 94(1):9-14. PubMed ID: 11262802
    [Abstract] [Full Text] [Related]

  • 16. [Local immunomodulating agents in complex treatment of oral lichen planus].
    Lukinykh LM, Tiunova NV.
    Stomatologiia (Mosk); 2013 Feb; 92(6):26-8. PubMed ID: 24429784
    [Abstract] [Full Text] [Related]

  • 17. [Modern approach to pathogenetic therapy of the oral mucosa lichen].
    Ivanova EV, Shcherbakova EG, Rabinovich OF, Barsukov AA, Ezhova EG, Vasilenko IA.
    Stomatologiia (Mosk); 2005 Feb; 84(5):28-31. PubMed ID: 16247390
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of recurrence of herpetic keratitis by an immunomodulator : levamisole].
    Vérin P.
    Bull Soc Ophtalmol Fr; 1981 Nov; 81(11):965-6. PubMed ID: 7340976
    [No Abstract] [Full Text] [Related]

  • 19. Levamisole in dermatology : a review.
    Scheinfeld N, Rosenberg JD, Weinberg JM.
    Am J Clin Dermatol; 2004 Nov; 5(2):97-104. PubMed ID: 15109274
    [Abstract] [Full Text] [Related]

  • 20. [The combined treatment of lichen ruber planus of the mouth mucosa].
    Volodina EV, Maksimovskiĭ IuM, Lebedev KA.
    Stomatologiia (Mosk); 1997 Nov; 76(2):28-32. PubMed ID: 9163080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.